Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indomethacin PK/PD in Extremely Preterm Neonates
NCT04025177Phase 2Withdrawn
- Sponsor
- University of Manitoba
- Start
- Jan 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of indomethacin in patent ductus arteriosus (PDA), sponsored by University of Manitoba. Planned start Jan 2020; status: withdrawn.
02
Drugs
indomethacin
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NCT04025177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04025177.